Invenio Imaging Gets CE Mark for Cancer-Detecting Artificial Intelligence Software

Santa Clara, Calif.-based Invenio Imaging has received a CE mark for its Nio Glioma Reveal laser image analysis software, which uses artificial intelligence to help neurosurgeons identify areas of cancer infiltration in patients undergoing treatment for a diffuse glioma.

The software can image multiple samples from a resection cavity and the system can be combined with other imaging techniques such as 5-ALA fluorescence to improve brain tumor detection during surgery, the company said.

Invenio has launched the Nio Glioma Reveal software in Europe, but the product is not yet approved or cleared in the U.S., where it is only available for research purposes.